9
Oct, 2020
A rapid COVID-19 saliva test could be used wherever crowds gatherMaria Rantanen / Richmond News A Richmond biomedical company is in a race to create a rapid, cheap and portable saliva test for COVID-19 to help open up the economy…
READ MORE
31
Mar, 2020
An amazing show of public support for UBC disease researcher Dr. Horciao Bach, who has started his COVID-19 antibody development project. Dr. Horacio Bach is one of BioMark’s scientific advisors and is expert on antibody engineering. He has received a major grant from CIHR for COVID- 19 antibody development. More information can be found at @DiseasesUbc
READ MORE
19
Aug, 2019
Vancouver, British Columbia – (August 19th, 2019) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that the article “Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot…
READ MORE
31
May, 2019
MAY 31, 2019 — Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and is characterized by its infiltrative and often fatal progression. The strikingly poor survival for patients with GBM of 14-16 months following diagnosis is due in part to limited early detection methods and an absence of effective treatment options. Funding from the Canadian Institute of Health Research of $753,432 was awarded to professor Donald Miller…
READ MORE